Karyopharm Therapeutics reported 325 in Employees for its fiscal year ending in December of 2023.





Employees Change Date
AbbVie 55K 5K Dec/2024
Abbott 114K 1000 Dec/2023
Amgen 28K 1.3K Dec/2024
AstraZeneca USD 89.9K 6.4K Dec/2023
BioCryst Pharmaceuticals 536 5 Dec/2023
Bristol-Myers Squibb 34.1K 0 Dec/2024
Eli Lilly 47K 4K Dec/2024
Enanta Pharmaceuticals 145 15 Sep/2023
GlaxoSmithKline 69.4K 20.7K Dec/2022
Incyte 2.62K 93 Dec/2024
J&J 138.1K 6.2K Dec/2024
Karyopharm Therapeutics 325 60 Dec/2023
MacroGenics 339 18 Dec/2023
Merck 75K 3K Dec/2024
Nektar Therapeutics 137 79 Dec/2023
Novartis USD 101.7K 2.62K Dec/2022
Novartis 101.7K 2.62K Dec/2022
Pfizer 81K 7K Dec/2024
Regeneron Pharmaceuticals 13.45K 1.6K Dec/2023
Roche Holding 103.61K 2.69K Dec/2022
Sangamo BioSciences 405 73 Dec/2023
Takeda 47.46K 1.83K Dec/2025
Tectonic Therapeutic 45 1 Dec/2023
TG Therapeutics 338 74 Dec/2024
Ultragenyx Pharmaceutical 1.29K 18 Dec/2024
Xencor 250 30 Dec/2024